<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>64</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>07</Month>
        <Day>05</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Expression Level of MicroRNA-122 in Serum Samples of Patients With Atherosclerosis</title>
    <FirstPage>183</FirstPage>
    <LastPage>189</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Samin</FirstName>
        <LastName>Aboulhassanzadeh</LastName>
        <affiliation locale="en_US">M&#xE9;rieux NutriSciences, Global, Advanced Laboratory Testing, Newbridge, Ireland. AND Research Center for Pharmaceutical Nanotechnology (RCPN), Tabriz University of Medical Sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hamed</FirstName>
        <LastName>Aghazadeh</LastName>
        <affiliation locale="en_US">Research Center for Pharmaceutical Nanotechnology (RCPN), Tabriz University of Medical Sciences, Tabriz, Iran. AND School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. AND Laboratory of Dendrimers and Nano-Biopolymers, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Nikkhooy</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Science, Shahid Chamran University, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra Sadat</FirstName>
        <LastName>Mousavian Hiagh</LastName>
        <affiliation locale="en_US">Laboratory of Dendrimers and Nano-Biopolymers, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Behboud</FirstName>
        <LastName>Jafari</LastName>
        <affiliation locale="en_US">Department of Microbiology, Ahar Branch, Islamic Azad University, Ahar, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sobhan</FirstName>
        <LastName>Aboulhassanzadeh</LastName>
        <affiliation locale="en_US">Research Center for Pharmaceutical Nanotechnology (RCPN), Tabriz University of Medical Sciences, Tabriz, Iran. AND School of Biotechnology, Faculty of Science and Health, Dublin City University, Dublin, Ireland.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>08</Month>
        <Day>18</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>26</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Atherosclerosis is another type of arteriosclerosis, characterized by the hardening of arteries, playing a significant role in various cardiovascular diseases. It stands as one of the leading causes of mortality in contemporary societies, especially in advanced countries experiencing higher levels of stress. The primary feature of atherosclerosis is the accumulation of excessive lipid deposits (plaques), obstructing blood flow and leading to strokes and various cardiovascular diseases. While various factors contribute to plaque formation, both environmental and genetic factors play crucial roles. In the cross-sectional study, 80 patients with atherosclerosis, referred to Rajaee Hospital in Tehran and Madani Hospital in Tabriz, along with 80 healthy individuals for comparative analysis, were selected. All relevant information and serum levels of important biomarkers were measured, followed by statistical analysis. MicroRNA extraction was performed using Trizol solution, and CDNA was synthesized by adding polyadenine tails to all microRNA samples. The obtained CDNA was utilized for real-time PCR with LNA primers. The results, normalized using Spike RNA, indicated a significant 90% decrease in the serum levels of these microRNAs in patients with atherosclerosis. The findings suggest that microRNA miR-122 could serve as a promising biomarker for diagnosing atherosclerosis.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/11207</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/11207/6037</pdf_url>
  </Article>
</Articles>
